Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European ...

The $16.5 billion take-private deal can now be completed, and along with it Novo Nordisk’s related acquisition of three ...

Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to ...

After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to ...

Novo Holdings in February agreed to buy Catalent to boost output of the popular weight-loss drug Wegovy. According to the ...

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target ...

Novo Holdings completes $16.5 billion acquisition of Catalent Inc, with Novo Nordisk A/S acquiring Catalent's fill-finish sites in Italy, USA, and Belgium.

A partnership between Novo Holdings and European energy will repower 17 operational wind parks in Germany with new and more efficient wind turbines. COPENHAGEN, Denmark, Dec. 23, 2024 /PRNewswire ...

Novo Nordisk will soon acquire from Novo Holdings Catalent’s three fill-finish sites located in Italy, the U.S., and Belgium.

Novo Holdings can proceed with its planned $16.5 billion acquisition of Catalent after U.S. regulators declined to challenge ...